Milestone Pharmaceuticals (NASDAQ:MIST) Rating Lowered to “Hold” at TD Securities
Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) was downgraded by analysts at TD Securities from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday,BayStreet.CA reports. Separately, HC Wainwright reissued a “buy” rating and issued a $25.00 price objective on shares of Milestone Pharmaceuticals in a research report on […]
Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) was downgraded by analysts at TD Securities from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday,BayStreet.CA reports. Separately, HC Wainwright reissued a “buy” rating and issued a $25.00 price objective on shares of Milestone Pharmaceuticals in a research report on […]
